COGT
Price
$14.88
Change
-$0.98 (-6.18%)
Updated
Oct 22, 11:27 AM (EDT)
Capitalization
2.22B
26 days until earnings call
Intraday Buy/Sell Signals
VTGN
Price
$4.02
Change
-$0.21 (-4.96%)
Updated
Oct 22, 12:38 PM (EDT)
Capitalization
129.78M
Intraday Buy/Sell Signals
Interact to see
Advertisement

COGT vs VTGN

Header iconCOGT vs VTGN Comparison
Open Charts COGT vs VTGNBanner chart's image
Cogent Biosciences
Price$14.88
Change-$0.98 (-6.18%)
Volume$248
Capitalization2.22B
VistaGen Therapeutics
Price$4.02
Change-$0.21 (-4.96%)
Volume$265
Capitalization129.78M
COGT vs VTGN Comparison Chart in %
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. VTGN commentary
Oct 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 22, 2025
Stock price -- (COGT: $15.86 vs. VTGN: $4.23)
Brand notoriety: COGT and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 143% vs. VTGN: 94%
Market capitalization -- COGT: $2.22B vs. VTGN: $129.78M
COGT [@Biotechnology] is valued at $2.22B. VTGN’s [@Biotechnology] market capitalization is $129.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $109.29B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 5 bearish.
  • VTGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а +2.79% price change this week, while VTGN (@Biotechnology) price change was +5.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.78%. For the same industry, the average monthly price growth was +16.12%, and the average quarterly price growth was +65.35%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($2.22B) has a higher market cap than VTGN($130M). COGT YTD gains are higher at: 103.333 vs. VTGN (43.390). VTGN has higher annual earnings (EBITDA): -58.99M vs. COGT (-299.34M). COGT has more cash in the bank: 238M vs. VTGN (63.2M). VTGN has less debt than COGT: VTGN (2.36M) vs COGT (60.7M). VTGN has higher revenues than COGT: VTGN (646K) vs COGT (0).
COGTVTGNCOGT / VTGN
Capitalization2.22B130M1,705%
EBITDA-299.34M-58.99M507%
Gain YTD103.33343.390238%
P/E RatioN/AN/A-
Revenue0646K-
Total Cash238M63.2M377%
Total Debt60.7M2.36M2,576%
FUNDAMENTALS RATINGS
COGT vs VTGN: Fundamental Ratings
COGT
VTGN
OUTLOOK RATING
1..100
7813
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3636
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (47) in the Biotechnology industry is somewhat better than the same rating for COGT (84) in the Miscellaneous industry. This means that VTGN’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (65) in the Miscellaneous industry is somewhat better than the same rating for VTGN (100) in the Biotechnology industry. This means that COGT’s stock grew somewhat faster than VTGN’s over the last 12 months.

VTGN's SMR Rating (98) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that VTGN’s stock grew similarly to COGT’s over the last 12 months.

VTGN's Price Growth Rating (36) in the Biotechnology industry is in the same range as COGT (36) in the Miscellaneous industry. This means that VTGN’s stock grew similarly to COGT’s over the last 12 months.

VTGN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that VTGN’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTVTGN
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 14 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASCCF27.02N/A
N/A
Asics Corp.
NXFNF3.65N/A
N/A
NEXT 15 GROUP PLC
RTOXF4.80N/A
N/A
Rotork PLC
RTGC0.37N/A
N/A
Ridder Titan Genesis Corp.
RENXF0.08N/A
N/A
Renalytix plc

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-2.22%
SPHDF - COGT
63%
Loosely correlated
N/A
NUVL - COGT
52%
Loosely correlated
-0.81%
IDYA - COGT
50%
Loosely correlated
-4.29%
CGON - COGT
49%
Loosely correlated
-1.22%
IMNM - COGT
48%
Loosely correlated
+3.02%
More